Journal article
Lu-177-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity In-111-octreotide
Daniel Hubble, Grace Kong, Michael Michael, Val Johnson, Shakher Ramdave, Rodney John Hicks
European Journal of Nuclear Medicine and Molecular Imaging | SPRINGER | Published : 2010
